NEW YORK – Qlucore said Thursday that it will collaborate with Semmelweis University in Budapest, Hungary, to develop a novel pan-cancer classification model.
In developing the model, the partners will use the Illumina TruSight RNA pan-cancer panel as well as Qlucore analytics and visualization technology.
Financial and other details of the partnership were not disclosed.
The molecular onco-hematology research group in the university's Department of Pathology and Experimental Cancer Research also became the second customer of Qlucore Diagnostics, a molecular diagnostics software product, the Lund, Sweden-based company said. Semmelweis will use the technology to improve diagnostics of acute lymphoblastic leukemia through gene fusion analysis.
"We look forward to using Qlucore's solutions for gene fusion analysis and subtyping based on gene expression signatures," Csaba Bödör, head of Semmelweis University's onco-hematology molecular diagnostic laboratory, said in a statement. "This makes it easier for us [to] complete gene fusion analysis with visual feedback of RNA-seq data from patients with leukemia and other cancer forms."